Allianz Asset Management’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-15,200
Closed -$29K 2455
2019
Q4
$29K Buy
+15,200
New +$28.1K ﹤0.01% 2745
2017
Q1
Sell
-54
Closed -$53K 2574
2016
Q4
$53K Hold
54
﹤0.01% 2553
2016
Q3
$47K Buy
+54
New +$42.4K ﹤0.01% 2545

Other funds holding ALT

Allianz Asset Management's ALT Position: Q1 2020 in Review

Allianz Asset Management sold out of Altimmune (ALT) in Q1 2020, closing a stake of 15,200 shares — an estimated $29K sold.

Allianz Asset Management first reported a position in ALT in Q3 2016 and held it in 3 quarters. The position peaked at $53K in Q4 2016. 29 funds tracked by Wall St. Rank hold ALT as of Q1 2020.

  • Allianz Asset Management reported no remaining Altimmune position as of Q1 2020 after selling out during the quarter.
  • Allianz Asset Management sold 15,200 Altimmune shares in Q1 2020, an estimated $29K.
  • Allianz Asset Management first reported a position in Altimmune in Q3 2016 and held it in 3 quarters.
  • Allianz Asset Management's Altimmune position peaked at $53K in Q4 2016.
  • 29 funds tracked by Wall St. Rank held Altimmune as of Q1 2020.

Based on Allianz Asset Management's 13F filing for Q1 2020, filed 14 May 2020.